A new age of genetic screening is coming — and we don’t have any rules for it
By Dalton Conley,
The Washington Post
| 06. 14. 2021
New ‘polygenic’ screening techniques open a Pandora’s Box of ethical issues.
After the coronavirus baby bust is over and fertility clinics are booming again, increasing numbers of new parents will bring home a generation of infants prescreened to perform better at school or basketball, resist heart disease or be less likely to have schizophrenia.
It may not be common yet, but the ability to screen embryos for any number of traits is here now, and improving every day. And this brave new world of genetic prediction I’m describing is not just about selecting babies during in vitro fertilization. It could also involve life insurance companies swabbing your cheek before issuing you a policy, preschools and colleges scoring your DNA as part of their admissions process and dating sites asking for your genetic profile before offering you a match.
But with this new technology comes countless ethical questions. Is embryo selection a good thing or a bad thing — or both? How do we balance potential inequities created against potential lives saved or improved? Do we want to keep genetics from becoming destiny, and what does that even mean? We desperately need...
Related Articles
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Lucy Tu, The Guardian | 11.05.2025
Beth Schafer lay in a hospital bed, bracing for the birth of her son. The first contractions rippled through her body before she felt remotely ready. She knew, with a mother’s pit-of-the-stomach intuition, that her baby was not ready either...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Robyn Vinter, The Guardian | 11.09.2025
A man going by the name “Rod Kissme” claims to have “very strong sperm”. It may seem like an eccentric boast for a Facebook profile page, but then this is no mundane corner of the internet. The group where Rod...